Marinomed Biotech AG (93Z) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Eye Drops, Solution In Single-Dose Container | Allergic Conjunctivitis, Allergic Rhinitis | Phase II | Completed | Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis | Aug 21, 2020 | ― |
| Rhinocort, Budesolv | Allergic Conjunctivitis, Allergic Rhinitis, Hayfever | Phase III | Completed | Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray | Nov 21, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Eye Drops, Solution In Single-Dose Container | Phase II | Allergic Conjunctivitis, Allergic Rhinitis | Completed | Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis | Aug 21, 2020 | ― |
| Rhinocort, Budesolv | Phase III | Allergic Conjunctivitis, Allergic Rhinitis, Hayfever | Completed | Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray | Nov 21, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Marinomed Biotech AG (DE:93Z) have in its pipeline
Marinomed Biotech AG DE:93Z is currently developing the following drugs: Eye Drops, Solution In Single-Dose Container, Rhinocort, Budesolv. These drug candidates are in various stages of clinical development as the company works toward FDA approval.